BioInvent International AB's total assets for Q1 2026 were kr534.96M, a decrease of -20.30% from the previous quarter. BOVNF total liabilities were kr95.85M for the fiscal quarter, a -15.61% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.